Determining similarity for biologics is much more challenging than with small molecules due to their larger size and greater structural complexity. Along with functional comparisons, measurement and analysis of the structural similarity between proteins is an effective method of demonstrating bioequivalence. MMS measures protein secondary structure, reveals very small conformation differences between different proteins, and provides information as to where those differences occur. These capabilities make MMS a powerful tool in the analysis and development of biosimilars.
Quantitating Protein Similarity
Protein similarity is a quantitative approach for detecting small changes in protein secondary structure by analyzing and comparing the amide I band spectra between proteins. As the amide I band is very sensitive to changes in protein secondary structure, the ability to measure small differences in the spectra can be a powerful tool in monitoring the biosimilarity of a protein. A number of algorithms have been proposed for this comparison, including the correlation coefficient and the area of overlap. These results can be compared to published results using other methods to assess the sensitivity of the MMS method relative to more traditional methods such as FTIR or UV-CD.
The following figure shows the overlaid second derivative spectra of a mAb run at a concentration of 0.5 mg/ mL on the AQS³pro. The spectra overlay with superior precision and the similarity of the measurements for samples run at both 0.5 mg/mL and 10 mg/mL are all above 98%.
For comparison, FTIR values found in the literature show a mean similarity of 86.37% +/- 7.98% at a single concentration of 10 mg/mL for HEWL (Hen Egg White Lysozyme). Using FTIR, protein similarity values at the 97% level could only be obtained at a concentration of 50 mg/mL. For all tested applications, the AQS³pro achieves better similarity with less deviation over a concentration range that far exceeds the measurement capability of FTIR, while also addressing the limitations of UV-CD which, limited dynamic range which requires dilutions to a concentration range of detection technology and interference with many formulation excipients causing issue with analysis of samples in relevant conditions.
*Data Source: Poster: Microfluidic Modulation Spectroscopy (MMS) - a novel automated infrared (IR) spectroscopic tool for secondary structure analysis of biopharmaceuticals with high sensitivity and repeatability; Dipanwita Batabyal et al.
Enter your details below and we'll send you the
Application Note on Microfluidic Modulation Spectroscopy
RedShift™, RedShiftBio®, See Change®, and AQS3™ are trademarks of RedShift BioAnalytics, Inc.